Collateral demands will be pro-cyclical - rising as markets become stressed - and will be generated by uncleared as well as cleared trades, DE Shaw treasurer tells Isda conference
Removing voice as an option would leave clients facing execution risk, says Isda chair Stephen O'Connor - but some buy-side firms see it differently
More Otc derivatives articles
Despite New Zealand’s domestic banking sector escaping the worst ravages of the recent financial crisis, the Reserve Bank of New Zealand is not wasting any time in introducing the Basel III framew...
Despite hard-won exemptions, corporates should consider the pros and cons of clearing, according to panellists at an ACT event - but treasurers remain unconvinced
Australia's latest consultation paper outlines only "incremental steps" to central clearing
A consultation on OTC clearing is expected in the coming months, but a key question will not be answered
A hammer to crack a nut, or a chance for everybody to win? Buy-side panellists disagree on the merits of central clearing
Market risk hedges should be recognised when calculating CVA capital charge, says HSBC market risk modelling head
Consistent reporting to multiple trade repositories under new OTC regulations will depend on the successful adoption of legal identifiers
Fears that a different approach to over-the-counter derivative regulations in Asia could prompt regulatory arbitrage with Europe and North America have been laid to rest by Singapore’s February co...
New derivatives regulation will require all derivatives trades to be reported to trade repositories – but some confusion exists over who has the responsibility to report
Default fund contributions will be too onerous for South African banks, say conference participants
Counterparties will have to post variation margin on uncleared trades – but questions remain over which firms will have to post and collect initial margin
Towards two-way CSAs
In response to industry fears of a collateral crunch, regulators have revised the proposed rules on margining for uncleared over-the-counter (OTC) derivatives.You can find out more by downloading this white paper here.